Delayed puberty in chronic illness

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 16, Issue 1, 2002, Pages 73-90

  Pozo, Jesús ^a   Argente, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Abnormal puberty; Chronic disease; Delayed puberty; Growth; Growth delay; Puberty

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CORTICOSTEROID; CORTICOTROPIN; DEFEROXAMINE; DIURETIC AGENT; GLUCOCORTICOID; GROWTH HORMONE; HYPOPHYSIS HORMONE; LAXATIVE; RECOMBINANT THYROTROPIN; STEROID; THYROID HORMONE; TOXIC SUBSTANCE; FOLLITROPIN; GONADORELIN; GONADOTROPIN; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; LIOTHYRONINE; LUTEINIZING HORMONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOSTATIN; TESTOSTERONE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AGE; ANEMIA; BONE DISEASE; BRAIN RADIATION; CHILDHOOD; CHRONIC DISEASE; DELAYED PUBERTY; DIALYSIS; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; EARLY DIAGNOSIS; EATING DISORDER; EMOTIONAL DEPRIVATION; ENDOCRINE DISEASE; ETHNOLOGY; EXERCISE; GASTROINTESTINAL DISEASE; GROWTH; GROWTH ACCELERATION; GROWTH CURVE; GROWTH DISORDER; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; IMMUNE DEFICIENCY; INCIDENCE; KIDNEY DISEASE; LONG TERM CARE; MALNUTRITION; ONSET AGE; PATHOPHYSIOLOGY; PROGNOSIS; PUBERTY; RECURRENT INFECTION; RESPIRATORY TRACT DISEASE; REVIEW; SEX DIFFERENCE; STRESS; SURVIVAL; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOREXIA NERVOSA; ASTHMA; BODY COMPOSITION; BODY HEIGHT; BONE MATURATION; BULIMIA; CANCER THERAPY; CELIAC DISEASE; CHRONIC KIDNEY FAILURE; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; ENERGY BALANCE; ENTERIC FEEDING; ENTERITIS; GAUCHER DISEASE; GIARDIA LAMBLIA; GIARDIASIS; GLOMERULONEPHRITIS; GONADOTROPIN RELEASE; GROWTH HORMONE DEFICIENCY; HEART DISEASE; HISTIOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCORTISOLISM; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE DISORDER; LEUKEMIA; LIOTHYRONINE BLOOD LEVEL; LIVER DISEASE; LIVER TRANSPLANTATION; MALABSORPTION; MENARCHE; MENSTRUAL CYCLE; MENTAL STRESS; PARENTERAL NUTRITION; PROTEIN CALORIE MALNUTRITION; SICKLE CELL ANEMIA; THALASSEMIA MAJOR; ZINC DEFICIENCY;

EID: 0036432251     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2002.0182     Document Type: Article

References (84)

1. Argente J. Diagnosis of late puberty. Hormone Research 1999; 51 (supplement 3): 95-100.
2. Albanese A & Stanhope R. Investigation of delayed puberty. Clinical Endocrinology 1995; 43: 105-110.
3. Albanese A & Stanhope R. Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty. Journal of Pediatrics 1995; 126: 545-550.
4. Finkelstein JS, Klibanski A & Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. Journal of Clinical Endocrinology and Metabolism 1996; 81: 1152-1155.
5. Pozo J & Argente J. Retraso constitucional del crecimiento y de la adolescencia. Endocrinología 1994; 41: 60-68.
6. Teresawa E & Fernández DL. Neurobiological mechanisms of the onset of puberty in primates. Endocrine Reviews 2001; 22: 111-151.
7. Preece MA, Law CM & Davies PSW. The growth of children with chronic paediatric disease. Clinical Endocrinology and Metabolism 1986; 15: 453-477.
8. Underwood LE. Growth retardation in chronic diseases: possible mechanisms. Acta Paediatrica 1999; 428 (supplement): 93-96.
9. Thissen JP & Ketelslegers JM. Endocrine response to undernutrition: from the experimental model to human physiology. In Prader A & Rappaport R (eds) Clinical Issues in Growth Disorders: Evaluation, Diagnosis, and Therapy pp 131-150 London, U.K. Freund Publishing House Ltd, 1994.
10. Thissen JP, Ketelslegers JM & Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrine Reviews 1994; 15: 80-101.
11. Argente J, Caballo N, Barrios V et al. Multiple endocrine abnormalities of the growth hormone (GH) and insulin-like growth factor (IGF) axes in patients with anorexia nervosa: effect of a short and long-term weight recuperation. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2084-2092.
12. Argente J, Muñoz MT, Pozo J et al. Growth hormone resistance in anorexia nervosa as a model of malnutrition. Journal of Endocrinology Investigation 1998; 21: 24-28.
13. Argente J, Barrios V, Chowen JA et al. Leptin plasma levels in healthy Spanish children and adolescents, children with obesity and adolescents with anorexia nervosa and bulimia nervosa. Journal of Pediatrics 1997; 131: 833-838.
14. Carro E, Señaris R, Considine RV et al. Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997; 138: 2203-2206
15. Kiess W, Reich A, Meyer K et al. A role for leptin in sexual maturation and puberty? Hormone Research 1999; 51 (supplement 3): 55-63.
16. Frish RE & McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974; 185: 949-951.
17. Black RE. Would control of childhood infectious diseases reduce malnutrition? Acta Paediatrica Scandinavica 1991; 374 (supplement): 133-140.
18. Kulin HE, Bwibo N, Mutie D & Santner SJ. The effect of chronic childhood malnutrition on pubertal growth and development. American Journal of Clinical Nutrition 1982; 36: 527-536.
19. Tovo PA, de Martino M, Gabiano C et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992; 339: 1249-1253.
20. Gertner JM, Kaufman FR, Donfield SM et al. Hemophilia Growth and Development Study. Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys. Journal of Pediatrics 1994; 124: 896-902.
21. Chiarelli F, Verrotti A, Galli L et al. Endocrine dysfunction in children with HIV-1 infection. Journal of Pediatric Endocrinology and Metabolism 1999; 12: 17-26.
22. Mahoney EM, Donfield SM, Howard C et al. Hemophilia Growth and Development Study. HIV-associated immune dysfunction and delayed pubertal development in a cohort of young hemophiliacs. Journal of Acquired Immune Deficiency Syndromes 1999; 21: 333-337.
23. Frost RA, Nachman SA, Lang CH & Gelato MC. Proteolysis of insulin-like growth factor-binding protein-3 in human immunodeficiency virus-positive children who fail to thrive. Journal of Clinical Endocrinology and Metabolism 1996; 81: 2957-2962.
24. Mulligan K, Tai VM & Schambelan MA. Clinical Research Center Study. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting. Journal of Clinical Endocrinology and Metabolism 1998; 83: 1542-1547.
25. Prasad AS. Clinical, endocrinological and biochemical effects of zinc deficiency. Clinical Endocrinology and Metabolism 1985; 14: 567-589.
26. Cacciari E, Corazza GR, Salardi S et al. What will be the adult height of coeliac patients? European Journal of Pediatrics 1991; 150: 407-409.
27. Hernández M, Argente J, Navarro A et al. Growth in malnutrition related to gastrointestinal diseases: coeliac disease. Hormone Research 1992; 38 (supplement 1): 79-84.
28. Molteni N, Bardella MT & Bianchi PA. Obstetric and gynecological problems in women with untreated celiac sprue. Journal of Clinical Gastroenterology 1990; 12: 37-39.
29. Walker-Smith JA. Management of growth failure in Crohn's disease. Archives of Disease in Childhood 1996; 75: 351-354.
30. Savage MO, Beattie RM, Camacho-Hübner C et al. Growth in Crohn's disease. Acta Paediatrica 1999; 428 (supplement): 89-92.
31. Shand WS. Surgical therapy of chronic inflammatory bowel disease in childhood. Baillière's Clinical Gastroenterology 1994; 8: 149-181.
32. Gokhale R, Favus MJ, Karrison T et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998; 114: 902-911.
33. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinology and Metabolism Clinics of North America 1996; 25: 699-718.
34. Markowitz J, Grancher K, Rosa J et al. Growth failure in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 1993; 16: 373-380.
35. Hildebrand H, Karlberg J & Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 1994; 18: 165-173.
36. Allen DB, Julius JR, Breen TJ & Attie KM. Treatment of glucocorticoid-induced growth suppression with growth hormone. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2824-2829.
37. Holt RIG, Jones JS, Stone NM et al. Sequential changes in insulin-like growth factor 1 (IGF-1) and IGF-binding protein in children with end-stage liver disease before and after successful orthotopic liver transplantation. Journal of Clinical Endocrinology and Metabolism 1996; 81: 160-168.
38. Viner RM, Forton JTM, Cole TJ et al. Growth of long term survivors of liver transplantation. Archives of Disease in Childhood 1999; 80: 235-240.
39. Sarna S, Sipilä I, Vihervuori E et al. Growth delay after liver transplantation in childhood: studies of underlying mechanisms. Pediatric Research 1995; 38: 366-372.
40. Sarna S, Sipilä I, Rönnholm K et al. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation. Journal of Clinical Endocrinology and Metabolism 1996; 81: 1476-1482.
41. Caldas A, Broyer M, Dechaux M & Kleinknecht C. Primary distal tubular acidosis in childhood: clinical study and long-term follow-up of 28 patients. Journal of Pediatrics 1992; 121: 233-241.
42. Broyer M, Tete MJ & Gubler MC. Late symptoms in infantile cystinosis. Pediatric Nephrology 1987; 1: 519-524.
43. Chik CL, Friedman A, Merrian GR & Gahl WA. Pituitary-testicular function in nephropathic cystinosis. Annals of Internal Medicine 1993; 119: 568-575.
44. Foote KD, Brocklebank JT & Meadow SR. Height attainment in children with steroid-responsive nephrotic syndrome. Lancet 1985; 26: 917-919.
45. Rees L, Greene SA, Adlard P et al. Growth and endocrine function in steroid-sensitive nephrotic syndrome. Archives of Disease in Childhood 1988; 63: 484-490.
46. Fine RN. Pathophysiology of growth retardation in children with chronic renal failure. Journal of Pediatric Endocrinology 1994; 7: 79-84.
47. Schaefer F, Seidel C, Binding A et al. Pubertal growth in chronic renal failure. Pediatric Research 1990; 28: 5-10.
48. Powell DR, Liu F, Baker BK et al. Effect of chronic renal failure and growth hormone therapy on the insulin-like growth factors and their binding proteins. Pediatric Nephrology 2000; 14: 579-583.
49. Handelsman DJ & Dong Q. Hypothalamo-pituitary-gonadal axis in chronic renal failure. Endocrinology and Metabolism Clinics of North America 1993; 22: 145-161.
50. Hokken-Koelega ACS, Van Zaal MAE, Van Bergen W et al. Final height and its predictive factors after renal transplantation in childhood. Pediatric Research 1994; 36: 323-328.
51. Maxwell H, Haffner D & Rees L. Catch-up growth occurs after renal transplantation in children of pubertal age. Journal of Pediatrics 1998; 133: 435-440.
52. Tönshoff B & Mehls O. Growth retardation in children with chronic renal disease - Pathophysiology and treatment. In Hindmarsh PC (ed.) Indications for Growth Hormone Therapy pp 128-156. Basel, Karger: Endocrine Development, 1999.
53. Russell G. Asthma and growth. Archives of Disease in Childhood 1993; 69: 695-698.
54. Allen DB, Mullen M & Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. Journal of Allergy and Clinical Immunology 1994; 93: 967-976.
55. Patel L, Clayton PE, Addison GM et al. Linear growth in prepubertal children with atopic dermatitis. Archives of Disease in Childhood 1998; 79: 169-172.
56. Shaw NJ, Fraser NC & Weller PH. Asthma treatment and growth. Archives of Disease in Childhood 1997; 77: 284-286.
57. Allen DB. Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective. Acta Paediatrica 1998; 87: 123-129.
58. Sproul A & Huang N. Growth patterns in children with cystic fibrosis. Journal of Pediatrics 1964; 65: 664-676.
59. Lai HC, Kosorok MR, Sondel SA et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. Journal of Pediatrics 1998; 132: 478-485.
60. Laursen EM, Koch C, Petersen JH & Müller J. Secular changes in anthropometric data in cystic fibrosis patients. Acta Paediatrica 1999; 88: 169-174.
61. Johannesson M, Gottlieb C & Hjelte L. Delayed puberty in girls with cystic fibrosis despite good clinical status. Pediatrics 1997; 99: 29-34.
62. Kattamis C, Liakopoulos T & Kattamis K. Growth and development in children with thalassaemia major. Acta Paediatrica Scandinavica 1990; 366 (supplement): 111-117.
63. Low CK. Growth, puberty and endocrine function in beta-thalassaemia major. Journal of Pediatric Endocrinology and Metabolism 1997; 10: 175-184.
64. Filosa A, Di Maio S, Baron I et al. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty. Acta Paediatrica 2000; 89: 1295-1301.
65. Chatterjee R & Katz M. Evaluation of gonadotrophin insufficiency in thalassemic boys with pubertal failure: spontaneous versus provocative test. Journal of Pediatric Endocrinology and Metabolism 2001; 14: 301-312.
66. Singhal A, Thomas P, Cook R et al. Delayed adolescent growth in homozygous sickle cell disease. Archives of Disease in Childhood 1994; 71: 404-408.
67. Leonard MB, Zemel BS, Kawchak DA et al. Plasma zinc status, growth and maturation in children with sickle cell disease. Journal of Pediatrics 1998; 132: 467-471.
68. Wajnrajch MP, Gertner JM, Huma Z et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744-754.
69. Choe YH, Kim SK & Hong YC. Helicobacter pylori infection with iron deficiency anaemia and subnormal growth at puberty. Archives of Disease in Childhood 2000; 82: 136-140.
70. Tanaka T. Puberty and growth in children with growth hormone deficiency. In Ranke MB & Wilton P (eds) Growth Hormone Therapy in KIGS. 10 Years' Experience, pp 81-91. Heidelberg: Barth, 1999.
71. Pansiotou S, Stanhope R, Uruena M et al. Growth prognosis and growth after menarche in primary hypothyroidism. Archives of Disease in Childhood 1991; 66: 838-840.
72. Van Wyk J & Grumbach MM. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap pituitary feedback. Journal of Pediatrics 1960; 57: 416-435.
73. Longcope C. The male and female reproductive systems in thyrotoxicosis. In Braverman LE & Utiger RD (eds) Werner & Ingbar's The Thyroid: A Fundamental And Clinical Text, 8th edn pp 652-658. Philadelphia: Lippincott Williams & Wilkins, 2000.
74. Buckler JMH, Willgerodt H & Keller E. Growth in thyrotoxicosis. Archives of Disease in Childhood 1986; 61: 464-471.
75. Zadik Z, Cooper M, Chen M & Stern N. Cushing's disease presenting as pubertal arrest. Journal of Pediatric Endocrinology 1993; 6: 201-204.
76. Lebrethon MC, Grossman AB, Afshar F et al. Linear growth and final height after treatment for Cushing's disease in childhood. Journal of Clinical Endocrinology and Metabolism 2000; 85: 3262-3265.
77. Connors MH. Growth in the diabetic child. Pediatric Clinics of North America 1997; 44: 301-306.
78. Muñoz MT, Barrios V, Pozo J & Argente J. Insulin-like growth factor 1 (IGF-1), its binding-proteins number 1 and 3 (IGFBP-1 and IGFBP-3) and growth hormone binding-protein (GHBP) in children and adolescents with insulin-dependent diabetes mellitus (IDDM): clinical implications. Pediatric Research 1996; 39: 992-998.
79. Couzinet B, Young J, Brailly S et al. Functional hypothalamic amenorrhea: a partial and reversible gonadotropin deficiency of nutritional origin. Clinical Endocrinology 1999; 50: 229-235.
80. Beunen GP, Malina RM, Thomis M. Physical growth and maturation of female gymnasts. In Johnston FE, Zemel B & Eveleth PB (eds) Human Growth In Context pp 281-289. London: Smith-Gordon 1999.
81. Jonnalagadda SS, Bernadot D & Nelson M. Energy and nutrient intakes of the United States National Women's Artistic Gymnastics Team. International Journal of Sports and Nutrition 1998; 8: 331-344.
82. Sundgot-Borgen J. Eating disorders, energy intake, training volume, and menstrual function in high-level modern rhythmic gymnasts. International Journal of Sports and Nutrition 1996; 6: 100-109.
83. Warren MP. Metabolic factors and the onset of puberty. In Grumbach MM, Sizonenko PC & Aubert ML (eds) Control of the Onset of Puberty Baltimore: Williams & Wilkins, 1990.
84. De Cree C. Sex steroid metabolism and menstrual irregularities in the exercising female. A review. Sports Medicine 1998; 6: 369-406.